Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody Responses to Epstein‐Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles
Sabrina Fechtner, Heather M. Berens, Elizabeth A. Bemis, et al.
Arthritis & Rheumatology (2021) Vol. 74, Iss. 4, pp. 597-603
Open Access | Times Cited: 21

Showing 21 citing articles:

Chronic viral coinfections differentially affect the likelihood of developing long COVID
Michael J. Peluso, Tyler‐Marie Deveau, Sadie E. Munter, et al.
Journal of Clinical Investigation (2022) Vol. 133, Iss. 3
Open Access | Times Cited: 146
The Role of Viral Infections in the Onset of Autoimmune Diseases
Bhargavi Sundaresan, Fatemeh Shirafkan, Kevin Ripperger, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 782-782
Open Access | Times Cited: 78
Epstein–Barr virus as a potentiator of autoimmune diseases
William H. Robinson, Shady Younis, Zelda Z. Love, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 11, pp. 729-740
Closed Access | Times Cited: 12
Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID
Michael J. Peluso, Tyler‐Marie Deveau, Sadie E. Munter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Mechanism‐driven strategies for prevention of rheumatoid arthritis
V. Michael Holers, Kristine A. Kuhn, M. Kristen Demoruelle, et al.
Rheumatology & autoimmunity (2022) Vol. 2, Iss. 3, pp. 109-119
Open Access | Times Cited: 25
The peculiar features, diversity and impact of citrulline-reactive autoantibodies
Bruno Raposo, Lars Klareskog, William H. Robinson, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 7, pp. 399-416
Closed Access | Times Cited: 3
The influences of perfluoroalkyl substances on the rheumatoid arthritis clinic
Yun Zhao, Hangbiao Jin, Jianli Qu, et al.
BMC Immunology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Management of postinfectious inflammatory arthritis
Hailey Baker, J. Kennedy Amaral, Robert T. Schoen
Current Opinion in Rheumatology (2024)
Closed Access | Times Cited: 2
Antibodies to Citrullinated Protein Antigens, Rheumatoid Factor Isotypes and the Shared Epitope and the Near-Term Development of Clinically-Apparent Rheumatoid Arthritis
Dylan T. Bergstedt, Wyatt Tarter, Ryan A. Peterson, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
How does age determine the development of human immune-mediated arthritis?
Yannick Degboé, Sebastiaan J. Vastert, Berent J. Prakken, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 9, pp. 501-512
Open Access | Times Cited: 11
Association between atopic dermatitis, autoimmune illnesses, Epstein-Barr virus, and cytomegalovirus
Zelma C. Chiesa Fuxench, Nandita Mitra, Ole Hoffstad, et al.
Archives of Dermatological Research (2023) Vol. 315, Iss. 9, pp. 2689-2692
Closed Access | Times Cited: 5
How to and should we target EBV in MS?
Svetlana Eckert, Dejan Jakimovski, Robert Zivadinov, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 7, pp. 703-714
Closed Access | Times Cited: 1
Markers of Epstein–Barr Virus Infection in Association with the Onset and Poor Control of Rheumatoid Arthritis: A Prospective Cohort Study
Danijela Miljanovic, Andja Ćirković, Ivica Jermic, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 1958-1958
Open Access | Times Cited: 4
What comes before scleroderma?
Silvia Bellando-Randone, Yossra A. Suliman, Sana Anwar, et al.
IntechOpen eBooks (2024)
Open Access | Times Cited: 1
Uncovering the Role of Epstein–Barr Virus Infection Markers for Remission in Rheumatoid Arthritis
Ana Banko, Andja Ćirković, Ivica Jeremić, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2375-2375
Open Access | Times Cited: 2
Distinct oral DNA viral signatures in rheumatoid arthritis: a Pilot study
Mahin Ghorbani, Nooshin Khoshdoozmasouleh
Journal of Oral Microbiology (2024) Vol. 16, Iss. 1
Open Access
Coordination and Collaboration to Support Exposome Research in Autoimmune Diseases
Victoria K. Shanmugam, Sarah M. Temkin, Janine A. Clayton, et al.
Arthritis Care & Research (2024)
Closed Access
Clinicopathologic Insights and Molecular Oncogenesis: Understanding Epstein-Barr Virus-Induced B-cell Lymphoproliferations
Adam S. Bronson, Yuanzhe Zhu, Cullen M. Lilley, et al.
International Journal of Surgical Pathology (2024)
Closed Access
Epigenetic regulation of Epstein–Barr virus: From bench to bedside
Xiao Gao, Hao‐Xu Yang, Shu Cheng, et al.
Clinical and Translational Discovery (2024) Vol. 4, Iss. 5
Open Access
Differences in Salivary Cytokinome and Pathogen Load Between Rheumatoid Arthritis and Other Rheumatic Disease Patients
Aleksandra Korzeniowska, Agnieszka Daca, Maria Szarecka, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 197-197
Open Access
Antibody proteomics
L.Sh. Kazieva, Tatiana Farafonova, Victor G. Zgoda
Biomeditsinskaya Khimiya (2023) Vol. 69, Iss. 1, pp. 5-18
Open Access
Page 1

Scroll to top